NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Viking Therapeutics Inc (NASDAQ: VKTX)

 
VKTX Technical Analysis
5
As on 9th Jun 2023 VKTX STOCK Price closed @ 24.27 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.31 & Strong Buy for SHORT-TERM with Stoploss of 3.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VKTXSTOCK Price

Open 24.70 Change Price %
High 25.06 1 Day -0.52 -2.10
Low 24.19 1 Week 2.96 13.89
Close 24.27 1 Month 4.39 22.08
Volume 1712300 1 Year 19.36 394.30
52 Week High 24.64 | 52 Week Low 2.11
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
VKTX
Daily Charts
VKTX
Intraday Charts
Whats New @
Bazaartrend
VKTX
Free Analysis
 
VKTX Important Levels Intraday
RESISTANCE25.95
RESISTANCE25.41
RESISTANCE25.08
RESISTANCE24.74
SUPPORT23.80
SUPPORT23.46
SUPPORT23.13
SUPPORT22.59
 
VKTX Forecast April 2024
4th UP Forecast26.99
3rd UP Forecast26.12
2nd UP Forecast25.58
1st UP Forecast25.04
1st DOWN Forecast23.5
2nd DOWN Forecast22.96
3rd DOWN Forecast22.42
4th DOWN Forecast21.55
 
VKTX Weekly Forecast
4th UP Forecast25.48
3rd UP Forecast25.09
2nd UP Forecast24.85
1st UP Forecast24.61
1st DOWN Forecast23.93
2nd DOWN Forecast23.69
3rd DOWN Forecast23.45
4th DOWN Forecast23.06
 
VKTX Forecast2024
4th UP Forecast69.94
3rd UP Forecast55.29
2nd UP Forecast46.24
1st UP Forecast37.19
1st DOWN Forecast11.35
2nd DOWN Forecast2.3
3rd DOWN Forecast-6.75
4th DOWN Forecast-21.4
 
 
VKTX Other Details
Segment EQ
Market Capital 466793088.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VKTX Address
VKTX
 
VKTX Latest News
 
Your Comments and Response on Viking Therapeutics Inc
 
VKTX Business Profile
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. Viking Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Address: 12340 El Camino Real, San Diego, CA, United States, 92130
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service